New Nanotherapy Offers Hope in Treating Drug-Resistant Renal Cell Carcinoma

Date posted
Funding Agency
(Funded by the National Science Foundation and the National Institutes of Health)

Scientists have used nanoparticles along with FDA-approved medication to effectively and selectively inhibit drug-resistant kidney cancer.